Tag: Symplicity
TCT 2022 hears “important data” from renal denervation trials
Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...
TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic has announced findings from a new study of patient preferences for the treatment of hypert...
EuroPCR 2021: Late-breaking data demonstrate long-term benefits of Medtronic radiofrequency renal denervation in real-world hypertensive patients
Medtronic today announced new clinical data from the Global SYMPLICITY registry (GSR) indicating...
Virtual ACC: Renal denervation bests sham control to safely lower blood pressure in patients with untreated hypertension
Three months after undergoing renal denervation, patients with untreated high blood pressure had...
EuroPCR 2019: Renal denervation linked to reduction in subclinical atrial fibrillation
Data presented at EuroPCR today indicates that renal denervation with the Symplicity system (Med...
CRT 2019: Redesigning the resurgence of renal denervation
David Kandzari (Atlanta, USA) tells Cardiovascular News at CRT 2019 that renal denervation is typ...
Renal denervation devices are alternatives to drug therapy, Technavio reports
Analysts from Technavio have forecast the global renal denervation market to grow at a compound annu...
